Exabis Library
Welcome to the e-CCO Library!
P213: Raised faecal calprotectin in inflammatory bowel disease (IBD) patients: 100% accurate or potential red herring?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P213: Risk factors associated with NAFLD and liver fibrosis in patients with Inflammatory Bowel Disease: a prospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P214 Low bone mineral density in inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P214: Cine MRI assessment of colonic motility in patients with ulcerative colitis associated constipation.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P214: Faecal S100A12 as a non-invasive marker of inflammatory activity in pediatric Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P214: How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committee
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P214: Inflammatory bowel disease and endometriosis: is there a relationship?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P214: Long-term outcomes of paediatric patients admitted for Acute Severe Colitis - a multicentre study from the paediatric IBD porto group of ESPGHAN
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P214: Plasma fatty acid binding protein 2, interleukin-10 and lipopolysaccharides as biomarkers for microscopic colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P214: What is the diagnostic accuracy of faecal calprotectin regarding endoscopic relapse in Crohn's disease patients following ileocecal resection? A tertiary single center experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P215 The effect of resection margin involvement of Crohn’s disease on the surgical and clinical recurrence after intestinal surgery
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P215: Blood-based prognostic biomarkers in Crohn’s patients treated with biologics: a new promising tool to predict endoscopic outcomes
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P215: Clinical features of chronic enteropathy associated with SLCO2A1 gene (CEAS)
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P215: Correlation between small bowel capsule endoscopy and biomarkers in postoperative recurrence in Crohn’s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P215: Deep immune phenotyping of unconventional T cells reveals a depletion in Mucosa Associated T Cells (MAIT) in IBD patients with extraintestinal manifestations
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P215: The determination of anti-saccharomyces cerevisiae antibodies at diagnosis of Crohn’s disease allows selecting a group of patients with higher risk of developing a complicated behaviour: A prospective study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P215: The influence of disease activity on birth outcomes in patients with inflammatory bowel disease: Meta- analysis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P215: The mean platelet volume compared with other serum biomarkers: is it predictive of activity of Crohn’s disease?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P216 Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P216: Comparative Assessment C-reactive Protein Between a Point-of-Care Testing and Current Standard of Care (Immunonephelometric testing)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM